Trial Profile
A Randomized, Open-label, Single Dose, 3x3 Partial Replicated Crossover Study to Evaluate the Pharmacokinetics and Safety/Tolerability Between a Fixed Dose Combination of Fimasartan 120mg/Atorvastatin 40mg and Co-administration of Fimasartan 120mg and Atorvastatin 40mg in Healthy Male Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 29 Mar 2018
Price :
$35
*
At a glance
- Drugs Atorvastatin/fimasartan (Primary) ; Atorvastatin; Fimasartan
- Indications Hypercholesterolaemia; Hypertension
- Focus Pharmacokinetics
- Sponsors Boryung Pharmaceutical
- 24 Mar 2018 Results (n=56) presented at the 119th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics.
- 16 Jan 2018 Status changed from recruiting to completed.
- 09 Aug 2017 Planned End Date changed from 1 Jun 2017 to 1 Aug 2017.